A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone

Clinical trial NCT06806852 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06806852
Sponsor: Boehringer Ingelheim
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2025-05-14
Primary completion: 2027-08-31
Enrollment: 91

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.